Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study.

Prinsen AMA, Wagensveld IM, Osses DF, Groenendijk PM, Zijta FM, Busstra MB, Rociu E, Barentsz JO, Sedelaar JPM, Arbeel B, Roeleveld T, Geenen R, Koeter I, van der Meer S, Cappendijk VC, Klaver S, van der Lely H, Wolters T, Leter MR, van der Poel HG, Heijmink SWTPJ, Immerzeel J, Leijte JAP, van Roermund JGH, Miclea RL, Planken E, Vis AN, de Jong IJ, Tijsterman J, Wolterbeek D, Claessen A, Nederend J, Bangma CH, Roobol MJ, Remmers S, van den Bergh RCN, Somford DM, Schoots IG

Open source

DOI
10.1016/j.euo.2025.11.002
Published
2026 Jun
Container
European urology oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.euo.2025.11.002,
  title = {Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study.},
  author = {Prinsen AMA and Wagensveld IM and Osses DF and Groenendijk PM and Zijta FM and Busstra MB and Rociu E and Barentsz JO and Sedelaar JPM and Arbeel B and Roeleveld T and Geenen R and Koeter I and van der Meer S and Cappendijk VC and Klaver S and van der Lely H and Wolters T and Leter MR and van der Poel HG and Heijmink SWTPJ and Immerzeel J and Leijte JAP and van Roermund JGH and Miclea RL and Planken E and Vis AN and de Jong IJ and Tijsterman J and Wolterbeek D and Claessen A and Nederend J and Bangma CH and Roobol MJ and Remmers S and van den Bergh RCN and Somford DM and Schoots IG},
  year = {2026},
  journal = {European urology oncology},
  doi = {10.1016/j.euo.2025.11.002},
  url = {https://doi.org/10.1016/j.euo.2025.11.002}
}

RIS

TY  - JOUR
TI  - Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study.
AU  - Prinsen AMA
AU  - Wagensveld IM
AU  - Osses DF
AU  - Groenendijk PM
AU  - Zijta FM
AU  - Busstra MB
AU  - Rociu E
AU  - Barentsz JO
AU  - Sedelaar JPM
AU  - Arbeel B
AU  - Roeleveld T
AU  - Geenen R
AU  - Koeter I
AU  - van der Meer S
AU  - Cappendijk VC
AU  - Klaver S
AU  - van der Lely H
AU  - Wolters T
AU  - Leter MR
AU  - van der Poel HG
AU  - Heijmink SWTPJ
AU  - Immerzeel J
AU  - Leijte JAP
AU  - van Roermund JGH
AU  - Miclea RL
AU  - Planken E
AU  - Vis AN
AU  - de Jong IJ
AU  - Tijsterman J
AU  - Wolterbeek D
AU  - Claessen A
AU  - Nederend J
AU  - Bangma CH
AU  - Roobol MJ
AU  - Remmers S
AU  - van den Bergh RCN
AU  - Somford DM
AU  - Schoots IG
PY  - 2026
JO  - European urology oncology
DO  - 10.1016/j.euo.2025.11.002
UR  - https://doi.org/10.1016/j.euo.2025.11.002
ER  -

APA

AMA, P., IM, W., DF, O., PM, G., FM, Z., MB, B., E, R., JO, B., JPM, S., B, A., T, R., R, G., I, K., S, V. D. M., VC, C., S, K., H, V. D. L., T, W., MR, L., HG, V. D. P., SWTPJ, H., J, I., JAP, L., JGH, V. R., RL, M., E, P., AN, V., IJ, D. J., J, T., D, W., A, C., J, N., CH, B., MJ, R., S, R., RCN, V. D. B., DM, S., & IG, S. (2026). Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study.. European urology oncology. https://doi.org/10.1016/j.euo.2025.11.002

Source records